EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In vitro and in vivo anticancer efficacy of the combination of actinomycin D and resveratrol

Lukmon M Raji iD, Rejina Afrin, Jihan Ferdaus Amin, Rajan Lamichhane, Krista L Denning, A R M Ruhul Amin iD

Biochemistry and Cell Biology · 2026

DOI: 10.1139/bcb-2025-0310 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemistry and Cell Biology, 2026. Verfasst von Lukmon M Raji und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Marshall University School of Pharmacy, Huntington, WV 25755, USA. Hauptthemen laut MEDLINE: Resveratrol, Dactinomycin, Stilbenes, Antineoplastic Agents. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: WV-INBRE, Marshall University School of Pharmacy, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Actinomycin D (Act D) was the first FDA-approved anticancer antibiotic. However, its widespread application was hindered by dose-limiting toxicities. In the current study, we investigated the in vitro and in vivo anticancer efficacy of the combination of Act D with resveratrol. We found that the combination of Act D and resveratrol has better in vitro efficacy than any of the single agent. We also explored the underlying mechanism by investigating the activation of the p53 pathway. Consistent with the cell growth inhibition, Act D, resveratrol, and their combination activated p53 and induced the expression of p21, PUMA, and GDF15 mRNA and proteins. The combination had better effects than any of the single agents alone. Ablation of p53 significantly protected cells and confirmed p53-dependent expression of these genes. Finally, we investigated the in vivo efficacy of these agents and their combination using xenograft model. Act D, resveratrol, and their combination significantly inhibited the growth of xenografts. The in vivo efficacy was further supported by Ki-67 expression in tumor tissues. Taken together, our findings demonstrated that although the combination of Act D and resveratrol showed better efficacy in vitro than any of the single agent, the in vivo efficacy was not improved.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ResveratrolDactinomycinStilbenesAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsHumansAnimalsCell Line, TumorMice, NudeXenograft Model Antitumor AssaysTumor Suppressor Protein p53MiceCell ProliferationGrowth Differentiation Factor 15Cyclin-Dependent Kinase Inhibitor p21Mice, Inbred BALB CProto-Oncogene ProteinsApoptosis Regulatory Proteins

Stichwörter der Autor:innen

GDF15actinomycin Dlung cancerp53resveratrol

Substanzen

ResveratrolDactinomycinTumor Suppressor Protein p53GDF15 protein, humanGrowth Differentiation Factor 15Cyclin-Dependent Kinase Inhibitor p21StilbenesBBC3 protein, humanAntineoplastic AgentsProto-Oncogene Proteins

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Marshall University School of Pharmacy, Huntington, WV 25755, USA.
  • Department of Pharmacy, East West University, Dhaka, Bangladesh.
  • Department of Clinical and Translational Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25755, USA.
  • Department of Pathology, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25755, USA.

ORCID-Profile: Lukmon M Raji, A R M Ruhul Amin

Förderung

  • WV-INBRE
  • Marshall University School of Pharmacy
  • NIH

Zitieren

APA

Raji, L., Afrin, R., Amin, J., Lamichhane, R., Denning, K., & Amin, A. (2026). In vitro and in vivo anticancer efficacy of the combination of actinomycin D and resveratrol. Biochemistry and Cell Biology. https://doi.org/10.1139/bcb-2025-0310

Vancouver

Raji L, Afrin R, Amin J, Lamichhane R, Denning K, Amin A. In vitro and in vivo anticancer efficacy of the combination of actinomycin D and resveratrol. Biochemistry and Cell Biology. 2026. doi:10.1139/bcb-2025-0310

BibTeX
@article{Raji2026,
  author = {Raji, Lukmon M and Afrin, Rejina and Amin, Jihan Ferdaus and Lamichhane, Rajan and Denning, Krista L and Amin, A R M Ruhul},
  title = {In vitro and in vivo anticancer efficacy of the combination of actinomycin D and resveratrol},
  journal = {Biochemistry and Cell Biology},
  year = {2026},
  doi = {10.1139/bcb-2025-0310}
}
Kostenlos starten →